Press Releases Latest May 31, 2022 Theratechnologies Announces New Head of Investor Relations Press Releases Year None2022202120202019201820172016201520142013 Nov 03, 2020 Theratechnologies Announces Departure Of Chief Commercial Officer Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020 Oct 16, 2020 Theratechnologies Appoints Two New Board Members Oct 15, 2020 Theratechnologies Announces Financial Results For The Third Quarter Of Fiscal 2020 Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH Oct 05, 2020 Theratechnologies To Announce Financial Results For Third Quarter 2020 Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5 Sep 21, 2020 Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results Sep 10, 2020 Theratechnologies Announces Launch Of Trogarzo® In Germany Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population First page « Previous page ‹ … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page › Last page » Displaying 61 - 70 of 281
Oct 22, 2020 Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020
Oct 13, 2020 Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From NAFLD/NASH
Sep 30, 2020 Theratechnologies To Present At The H.C. Wainwright 4th Annual NASH Investor Conference On October 5
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
